Danielle Bouchard
Primary Care · Palm Springs, CANPI 1518549054
Payments from drug & device makers
Across 39 payments — averaging $32.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$170
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$154
- Amgen$124
- Bayer$123
- Actelion Pharmaceuticals US, Inc.$97
- Silk Road Medical, Inc.$93
- plus $487 from 16 others
What the payments were for
- Food & beverage$1,249100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 12 | $170 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $154 |
| Amgen | 2 | $124 |
| Bayer | 1 | $123 |
| Actelion Pharmaceuticals US, Inc. | 1 | $97 |
| Silk Road Medical, Inc. | 3 | $93 |
| Baxter Healthcare | 1 | $61 |
| Atricure, Inc. | 1 | $48 |
| Boehringer Ingelheim | 2 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Biosense Webster, Inc. | 1 | $38 |
| Myriad Genetic Laboratories, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Mindray DS USA, Inc. | 1 | $26 |
| Solventum Corporation | 1 | $24 |
| Lemaitre Vascular, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $23 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
| Edwards Lifesciences | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $18 |
| AbbVie | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,249 in reported general payments places this provider in the 75th percentile of 706 primary care providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $26,767 |
| Repatha SureclickEvolocumab | 14 | $7,856 |
| Enoxaparin Sodium | 11 | $583 |
| ClopidogrelClopidogrel Bisulfate | 30 | $340 |
| Rosuvastatin Calcium | 29 | $284 |
| Atorvastatin Calcium | 31 | $224 |
| Chlorthalidone | 16 | $148 |
| Ezetimibe | 16 | $119 |
Paid to pharmacies, not to this prescriber.
Other primary care in Palm Springs
- Leslie FletcherTorrance$1.8M
- Hamideh PourzandLos Angeles$103K
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Joann BallPalm Desert$56K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
- Ashley LoweSan Diego$19K
- Vanessa LeeLong Beach$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.